Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care
Canadian Nurse Practitioner Journal · 2025
DOI: 10.28984/cnpj.v5i2.475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Nurse Practitioner Journal, 2025. Verfasst von Rianne Carragher und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Langzeitpflege, Demenz
Abstract (Originalsprache)
Background
The aim of this study was to explore most responsible providers’ acceptance and perceptions of prescribing nabilone and authorizing THC/CBD oil for the management of behavioural and psychological symptoms of dementia (BPSD) in people living with dementia.
Methods
A cross-sectional survey was sent to 9 most responsible providers (MRP) of residents with dementia residing in long-term care settings. The participant sample included 8 nurse practitioners and 1 physician.
Results
Data were analysed using survey outcome categories: MRP acceptance of nabilone for BPSD; MRP perception of nabilone; MRP acceptance of THC/CBD oil for BPSD; and MRP perceptions of THC/CBD oil. Participants considered BPSD to be managed somewhat well (77.8%) or very well (22.2%) in their resident population. More than half (66.7%) of participants have previously prescribed nabilone to manage BPSD, and 55.6% have trialed THC/CBD oil. Only 12.5% reported they were prepared to answer a resident or family member’s questions regarding nabilone “a great deal” (0% for THC/CBD oil), and 37.5% reported “quite a bit”. However, participants indicated they were less prepared to answer questions regarding THC/CBD oil. The participants felt that nabilone prescription for BPSD could “somewhat improve” quality-of-life indicators including physical functioning (71.4%); energy levels (57.1%); mood (100%); enjoyment of life (100%); social engagement (85.7%); ability to perform activities of daily living (57.1%); and sense of hope (83.3%).
Conclusion
Participants believed that nabilone and THC/CBD could improve quality-of-life outcomes in their residents living with dementia, including physical functioning and mood outcomes. Most participants believed that nabilone and THC/CBD oil could effectively treat BPSD, however, some participants reported a lack of confidence in answering resident or family questions about cannabinoid treatments. Further research is required to understand MRP acceptance and perceptions of specific cannabinoid products for BPSD in long-term care settings.
Zitieren
APA
Carragher, R., Woo, K., Smith, M., & Sawhney, M. (2025). Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care. Canadian Nurse Practitioner Journal. https://doi.org/10.28984/cnpj.v5i2.475
Vancouver
Carragher R, Woo K, Smith M, Sawhney M. Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care. Canadian Nurse Practitioner Journal. 2025. doi:10.28984/cnpj.v5i2.475
BibTeX
@article{Carragher2025,
author = {Carragher, Rianne and Woo, Kevin and Smith, Mary and Sawhney, Mona},
title = {Most Responsible Providers’ Acceptance and Perceptions of Nabilone and THC/CBD Oil for Dementia Behaviours in Long-Term Care},
journal = {Canadian Nurse Practitioner Journal},
year = {2025},
doi = {10.28984/cnpj.v5i2.475}
}
EUVIMED